Literature DB >> 31192861

Clinicopathologic Features and Calcium Deposition Patterns in Calciphylaxis: Comparison With Gangrene, Peripheral Artery Disease, Chronic Stasis, and Thrombotic Vasculopathy.

Emily R McMullen1, Paul W Harms1,2, Lori Lowe1,2, Douglas R Fullen1,2, May P Chan1,2.   

Abstract

Diagnosis of calciphylaxis is crucial, yet its distinction from other vascular diseases can be challenging. Although vascular calcification and thrombosis are hallmarks of calciphylaxis, the incidence and patterns of these features in other vascular diseases have not been well characterized. The specificity of fine calcium deposits in vessel walls (identifiable on von Kossa [VK] stain only) and other extravascular calcifications is not entirely clear. We retrospectively examined the clinicopathologic features in calciphylaxis (n=27), gangrene and viable skin at amputation margin (n=20 each), chronic stasis (n=22), and thrombotic vasculopathy (n=19) to identify useful discriminators. Calcification of subcutaneous small vessels appreciable on hematoxylin and eosin stain was relatively specific for calciphylaxis, although sensitivity was low (56%). VK detected fine calcium deposits in vessel walls not appreciable on hematoxylin and eosin, however, specificity was limited by frequent finding of similar deposits in peripheral artery disease. Combining calcium deposits detected by VK and thrombosis of subcutaneous small vessels resulted in optimal sensitivity (85%) and specificity (88%) for calciphylaxis. Similar observations applied to medium-sized vessel calcification. Calcification of eccrine gland basement membranes, elastic fibers, and perineurium did not effectively distinguish calciphylaxis from other groups. Diffuse dermal angiomatosis was exclusively found in calciphylaxis in this study. In conclusion, VK is useful in enhancing the detection of vascular calcification and avoiding the false-negative diagnosis, but this finding requires concomitant subcutaneous small vessel thrombosis to support a diagnosis of calciphylaxis. Diffuse dermal angiomatosis should increase suspicion for underlying calciphylaxis and prompt deeper sampling in the appropriate clinical setting.

Entities:  

Mesh:

Year:  2019        PMID: 31192861     DOI: 10.1097/PAS.0000000000001302

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

Review 1.  An update on vascular calcification and potential therapeutics.

Authors:  Anubha Singh; Simran Tandon; Chanderdeep Tandon
Journal:  Mol Biol Rep       Date:  2021-01-04       Impact factor: 2.316

2.  Use of the optimized sodium thiosulfate regimen for the treatment of calciphylaxis in Chinese patients.

Authors:  Xin Yang; Yuqiu Liu; Xiaotong Xie; Wen Shi; Jiyi Si; Xiaomin Li; Xiaoliang Zhang; Bicheng Liu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

3.  Nonuremic calciphylaxis manifesting with diffuse dermal angiomatosis.

Authors:  Francine T Castillo; Ritesh Agnihothri; Lindy P Fox; Jeffrey P North; Anna K Haemel
Journal:  JAAD Case Rep       Date:  2022-04-04

4.  Case Report: Idiopathic Subcutaneous Thrombotic Vasculopathy.

Authors:  Kerilyn Godbe; Ashlie Elver; Peter Chow; Chris Williams; Garth Fraga; Penelope Harris; Mohammed Taha; Dhaval Bhavsar; Richard Korentager
Journal:  Front Med (Lausanne)       Date:  2022-04-15

Review 5.  Vascular Calcification-New Insights Into Its Mechanism.

Authors:  Sun Joo Lee; In-Kyu Lee; Jae-Han Jeon
Journal:  Int J Mol Sci       Date:  2020-04-13       Impact factor: 5.923

Review 6.  The Effects of Warfarin and Direct Oral Anticoagulants on Systemic Vascular Calcification: A Review.

Authors:  Kalaimani Elango; Awad Javaid; Banveet K Khetarpal; Sathishkumar Ramalingam; Krishna Prasad Kolandaivel; Kulothungan Gunasekaran; Chowdhury Ahsan
Journal:  Cells       Date:  2021-03-31       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.